Michael J. Fallon

695 total citations
24 papers, 450 citations indexed

About

Michael J. Fallon is a scholar working on Surgery, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael J. Fallon has authored 24 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael J. Fallon's work include Acute Myeloid Leukemia Research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Michael J. Fallon is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Michael J. Fallon collaborates with scholars based in United States, United Kingdom and Australia. Michael J. Fallon's co-authors include I. Morris, Stephen Davis, John Ferguson, P Drury, Ashu Gupta, Christopher Frazer, Lesley Cala, Michael J. MacDonald, M. Bewick and B. Sean Carey and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Michael J. Fallon

24 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Fallon United States 10 110 110 96 84 63 24 450
C. Mittermayer Austria 12 243 2.2× 32 0.3× 12 0.1× 48 0.6× 41 0.7× 34 554
Inge A. H. van den Berk Netherlands 11 43 0.4× 78 0.7× 21 0.2× 19 0.2× 24 0.4× 29 446
Siddharth Shah United States 12 87 0.8× 24 0.2× 18 0.2× 5 0.1× 96 1.5× 39 589
Michel Goldman Belgium 8 45 0.4× 14 0.1× 25 0.3× 9 0.1× 61 1.0× 16 435
Kari V. Lunsford United States 11 87 0.8× 24 0.2× 50 0.5× 8 0.1× 31 0.5× 14 347
Harish Seethamraju United States 15 400 3.6× 17 0.2× 14 0.1× 179 2.1× 123 2.0× 51 906
Estela Paz‐Artal Spain 15 48 0.4× 19 0.2× 4 0.0× 66 0.8× 72 1.1× 35 702
Karla Laís Pêgas Brazil 10 110 1.0× 14 0.1× 5 0.1× 104 1.2× 33 0.5× 44 405
Anuja Java United States 13 35 0.3× 48 0.4× 5 0.1× 56 0.7× 93 1.5× 39 650
Leopold Stiebellehner Austria 14 115 1.0× 73 0.7× 6 0.1× 8 0.1× 89 1.4× 27 941

Countries citing papers authored by Michael J. Fallon

Since Specialization
Citations

This map shows the geographic impact of Michael J. Fallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Fallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Fallon more than expected).

Fields of papers citing papers by Michael J. Fallon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Fallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Fallon. The network helps show where Michael J. Fallon may publish in the future.

Co-authorship network of co-authors of Michael J. Fallon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Fallon. A scholar is included among the top collaborators of Michael J. Fallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Fallon. Michael J. Fallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brunner, Matthew, Michael J. Fallon, Ryan J. Mattison, et al.. (2024). Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia. JCO Precision Oncology. 8(8). e2300518–e2300518. 1 indexed citations
2.
3.
Fallon, Michael J., et al.. (2022). Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation. Journal of Oncology Pharmacy Practice. 29(5). 1094–1102. 5 indexed citations
4.
Fallon, Michael J., et al.. (2021). Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia. Journal of Oncology Pharmacy Practice. 27(7). 1779–1783. 3 indexed citations
5.
Mushtaq, Muhammad Umair, Alexandra M. Harrington, Sibgha Gull Chaudhary, et al.. (2020). Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma. 62(1). 158–166. 15 indexed citations
6.
Fallon, Michael J., et al.. (2020). Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice. Journal of Oncology Pharmacy Practice. 26(6). 1374–1381. 3 indexed citations
7.
8.
Fallon, Michael J., et al.. (2014). Fatal Stevens–Johnson syndrome/toxic epidermal necrolysis induced by allopurinol–rituximab–bendamustine therapy. Journal of Oncology Pharmacy Practice. 21(5). 388–392. 9 indexed citations
9.
Rose, Warren E., Michael J. Fallon, John J. Moran, & Joshua P. Vanderloo. (2012). Vancomycin Tolerance in Methicillin-Resistant Staphylococcus aureus: Influence of Vancomycin, Daptomycin, and Telavancin on Differential Resistance Gene Expression. Antimicrobial Agents and Chemotherapy. 56(8). 4422–4427. 23 indexed citations
10.
Fallon, Michael J. & Michael J. MacDonald. (2008). β-Cell α-ketoglutarate hydroxylases may acutely participate in insulin secretion. Metabolism. 57(8). 1148–1154. 7 indexed citations
11.
Smith, David W., et al.. (2005). Murray valley encephalitis mimicking herpes simplex encephalitis. Journal of Clinical Neuroscience. 12(7). 822–824. 11 indexed citations
12.
Thickbroom, Gary W., Michelle L. Byrnes, I. Morris, et al.. (2004). Functional MRI near vascular anomalies: comparison of cavernoma and arteriovenous malformation. Journal of Clinical Neuroscience. 11(8). 845–848. 23 indexed citations
13.
MacDonald, Michael J., et al.. (2003). Citrate Oscillates in Liver and Pancreatic Beta Cell Mitochondria and in INS-1 Insulinoma Cells. Journal of Biological Chemistry. 278(51). 51894–51900. 50 indexed citations
14.
Gupta, Ashu, Christopher Frazer, John Ferguson, et al.. (1999). Acute Pulmonary Embolism: Diagnosis with MR Angiography. Radiology. 210(2). 353–359. 144 indexed citations
15.
Carey, B. Sean, Robert W. Vaughan, Michael J. Fallon, et al.. (1997). Modulation of Anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients. Transplantation Proceedings. 29(1-2). 1448–1448. 6 indexed citations
16.
D’Souza, Richard, J.T.C. Kwan, Bruce M. Hendry, Michael J. Fallon, & David Cunningham. (1997). Successful outcome of treating hemolytic uremic syndrome associated with cancer chemotherapy with immunoadsorption.. PubMed. 47(1). 58–9. 6 indexed citations
17.
Carey, B. Sean, Robert W. Vaughan, Michael J. Fallon, et al.. (1996). Anticipation of highly sensitised renal patients’ immunoadsorption requirements by prescreening using protein A minicolumns. Transplant International. 9 Suppl 1. 20–24. 4 indexed citations
18.
Higgins, R., B. Sean Carey, Michael J. Fallon, et al.. (1996). Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. The Lancet. 348(9036). 1208–1211. 89 indexed citations
19.
Carey, B. Sean, Robert W. Vaughan, Michael J. Fallon, et al.. (1996). Anticipation of highly sensitised renal patients' immunoadsorption requirements by prescreening using protein A minicolumns. Transplant International. 9(s1). S20–S24. 3 indexed citations
20.
Fallon, Michael J., Vincent H. S. Low, & Lawrence Yu. (1994). Mucinous cystadenoma of the appendix with unusual sonographic appearances. Australasian Radiology. 38(4). 339–341. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Mittermayer Breakdown of academic impact, for papers by Inge A. H. van den Berk Breakdown of academic impact, for papers by Siddharth Shah Breakdown of academic impact, for papers by Michel Goldman Breakdown of academic impact, for papers by Kari V. Lunsford Breakdown of academic impact, for papers by Harish Seethamraju Breakdown of academic impact, for papers by Estela Paz‐Artal Breakdown of academic impact, for papers by Karla Laís Pêgas Breakdown of academic impact, for papers by Anuja Java Breakdown of academic impact, for papers by Leopold Stiebellehner
Rankless by CCL
2026